Qube Research & Technologies LTD Becton Dickinson & CO Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,027,822 shares of BDX stock, worth $245 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
1,027,822
Previous 850,792
20.81%
Holding current value
$245 Million
Previous $199 Million
24.63%
% of portfolio
0.38%
Previous 0.32%
Shares
20 transactions
Others Institutions Holding BDX
# of Institutions
1,734Shares Held
250MCall Options Held
690KPut Options Held
787K-
Vanguard Group Inc Valley Forge, PA26.6MShares$6.32 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.3 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$3.32 Billion0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13.6MShares$3.24 Billion0.38% of portfolio
-
Morgan Stanley New York, NY11MShares$2.61 Billion0.2% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $67.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...